Latigo Biotherapeutics, Inc. · NASDAQ:LTGO

Latigo Biotherapeutics, Inc. shareholders

As of Sep 30, 2026, 55 institutions reported holding Latigo Biotherapeutics, Inc., 63.0% of its shares. Largest: 5AM Venture Management, LLC, Ra Capital Management, L.P. and Deep Track Capital, LP. New holders, exits, insiders and big stakes, each with its filing.

HolderShares% of Latigo Biotherapeutics, Inc.ChangeFiled
5AM Venture Management, LLC7.33M11.0%newNov 16, 2026
Ra Capital Management, L.P.5.3M8.0%newNov 16, 2026
Deep Track Capital, LP4.41M6.6%newNov 16, 2026
Blue Owl Capital Holdings LP3.6M5.4%newNov 13, 2026
Foresite Capital Management V, LLC3.56M5.4%newNov 16, 2026
Fidelity2.88M4.3%newNov 10, 2026
Foresite Capital Management VI LLC2.2M3.3%newNov 16, 2026
Cormorant Asset Management, LP1.82M2.7%newNov 16, 2026
Orbimed Advisors LLC1.68M2.5%newNov 16, 2026
Vanguard1M1.5%newNov 13, 2026

Latigo Biotherapeutics, Inc. insider trades